<i>Corynebacterium striatum</i> Bacteremia during SARS-CoV2 Infection: Case Report, Literature Review, and Clinical Considerations

• Main Authors: Andrea Marino (Author), Edoardo Campanella (Author), Stefano Stracquadanio (Author), Manuela Ceccarelli (Author), Aldo Zagami (Author), Giuseppe Nunnari (Author), Bruno Cacopardo (Author)
• Format: Book
• Published: MDPI AG, 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.3390/idr14030042; 2036-7449
• Keywords: <i>Corynebacterium striatum</i>; Corynebacterial infections; Corynebacterial bacteremia; Other systems of medicine; RZ201-999
• Source: Infectious Disease Reports, Vol 14, Iss 3, Pp 383-390 (2022)

Bacterial infections, especially those in hospital settings, represent a major complication of COVID-19 patients, complicating management and worsening clinical outcomes. <i>Corynebacterium striatum</i> is a non-diphtheric actinobacterium that has been reported as being the causative agent of several different infections, affecting both immunocompetent and immunocompromised patients. Recently, <i>C. striatum</i> has been recognized as a nosocomial pathogen that is responsible for severe infection in critical patients, as well as in fragile and immunocompromised subjects. <i>C. striatum</i> has been described as the etiological agent of bacteremia, central line infections, and endocarditis. We report a case of a 91-year-old woman who was hospitalized due to SARS-CoV-2 infection, who developed <i>C. striatum</i> bacteremia and died despite antimicrobial therapy and clinical efforts. Furthermore, we discuss <i>C. striatum</i> diagnosis and treatment based on evidence from the scientific literature.